Using logistic regression, several tests were performed to evaluate the influence of sex, age and/or type of fusion (minor vs. Major BCR fusion [for ABL1 breakpoints in ALL patients]). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.